These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15474693

  • 21. [Brain natriuretic peptide and QRS duration as a predictor for cardiac events in patients with heart failure].
    Taniguchi T, Kawasaki T, Miyai N, Kamitani T, Kawasaki S, Sugihara H.
    J Cardiol; 2006 Jun; 47(6):277-83. PubMed ID: 16800370
    [Abstract] [Full Text] [Related]

  • 22. Changes in the Doppler myocardial performance index during dobutamine echocardiography: association with neurohormonal activation and prognosis after acute myocardial infarction.
    Nørager B, Husic M, Møller JE, Bo Hansen A, Pellikka PA, Egstrup K.
    Heart; 2006 Aug; 92(8):1071-6. PubMed ID: 16387817
    [Abstract] [Full Text] [Related]

  • 23. Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism.
    Pieralli F, Olivotto I, Vanni S, Conti A, Camaiti A, Targioni G, Grifoni S, Berni G.
    Am J Cardiol; 2006 May 01; 97(9):1386-90. PubMed ID: 16635617
    [Abstract] [Full Text] [Related]

  • 24. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.
    Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):742-8. PubMed ID: 16487838
    [Abstract] [Full Text] [Related]

  • 25. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ, Zareba W, Bisognano JD.
    Am J Cardiol; 2007 Apr 15; 99(8):1143-5. PubMed ID: 17437744
    [Abstract] [Full Text] [Related]

  • 26. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2007 May 15; 49(19):1943-50. PubMed ID: 17498579
    [Abstract] [Full Text] [Related]

  • 27. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L.
    J Cardiovasc Med (Hagerstown); 2009 Sep 15; 10(9):671-6. PubMed ID: 19444135
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM, Zaninotto M, Bacchiega E, Nalli C, Forni M, Tiso E, Cacciavillani L, Razzolini R, Plebani M.
    Ital Heart J; 2005 Feb 15; 6(2):125-32. PubMed ID: 15819505
    [Abstract] [Full Text] [Related]

  • 34. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT.
    Am J Cardiol; 2009 Jan 01; 103(1):73-5. PubMed ID: 19101233
    [Abstract] [Full Text] [Related]

  • 35. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R, Alibay Y, Brun-Ney D, Boulard JC, Dubourg O, Puy H, Jondeau G.
    Arch Mal Coeur Vaiss; 2006 Mar 01; 99(3):201-7. PubMed ID: 16618022
    [Abstract] [Full Text] [Related]

  • 36. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome.
    Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC, Enriquez-Sarano M.
    Circulation; 2005 May 10; 111(18):2391-7. PubMed ID: 15883225
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1079-88. PubMed ID: 17349888
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.